Early determinants of atherosclerosis in paediatric systemic lupus erythematosus

被引:0
|
作者
Boros, C. A. [1 ,6 ,9 ]
Bradley, T. J. [2 ,9 ]
Cheung, M. M. H. [2 ,9 ]
Bargman, J. M. [5 ,7 ]
Russell, J. L. [2 ,9 ]
McCrindle, B. W. [2 ,9 ]
Adeli, K. [3 ]
Hamilton, J. [4 ,9 ]
Silverman, E. D. [1 ,6 ,8 ,9 ]
机构
[1] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Div Clin Biochem, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada
[5] Toronto Gen Hosp, Div Nephrol, Toronto, ON, Canada
[6] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[9] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
关键词
vascular testing; cardiovascular risk factors; lipids; insulin resistance; LOW-DENSITY-LIPOPROTEIN; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; MYOCARDIAL-PERFUSION; YOUNG-ADULTS; WOMEN; CHILDREN; DISEASE; HOMOCYSTEINE; PROGRESSION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess traditional and non-traditional cardiovascular risk factors and to determine the prevalence and correlates of early vascular markers of atherosclerosis in paediatric systemic lupus erythematosus (pSLE). Methods Fifty-four adolescents with pSLE had cardiovascular risk factor assessment, disease activity and vascular testing including carotid intima-media thickness (CIMT), flow-mediated dilatation (FMD), arterial stiffness measures, and myocardial perfusion studies. Results The traditional risk factors of hypertension, elevated triglycerides, apolipoprotein B, haemoglobin AI c and insulin levels and non-traditional risk factors of elevated homocysteine and fibrinogen were present (all p<0.001). Some arterial stiffness measures, central pulse wave velocity and characteristic impedance were elevated (p<0.001), but CIMT, FMD and myocardial perfusion were normal. Cumulative prednisone dose correlated with total cholesterol (r=0.5790, p<0.001) and elevated LDL-C (r=0.4488, p=0.0012). Hydroxychloroquine treatment correlated negatively with total cholesterol (r=-0.4867, p=0.0002), LDL-C (r=-0.4805, p=0.0002) and apolipoprotein B (r=-0.4443, p=0.0011). In multivariate analysis LDL-C correlated with cumulative prednisone dose and negatively with hydroxychloroquine treatment (R-2=0.40, p<0.001). Conclusions An increased burden of traditional and non-traditional risk factors and early evidence of insulin resistance and increased central arterial stiffness were present in paediatric SLE. Disease-specific and therapy-related factors are likely modifying these cardiovascular risk profiles warranting prospective longitudinal studies.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 50 条
  • [41] Adipokines as novel biomarkers in paediatric systemic lupus erythematosus
    Al, Marjon
    Ng, Lawrence
    Tyrrell, Pascal
    Bargman, Joanne
    Bradley, Timothy
    Silverman, Earl
    RHEUMATOLOGY, 2009, 48 (05) : 497 - 501
  • [42] Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus
    Wierzbicki, AS
    LUPUS, 2000, 9 (03) : 194 - 201
  • [43] Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus
    Lourdudoss, C.
    Elkan, A-C
    Hafstrom, I.
    Jogestrand, T.
    Gustafsson, T.
    van Vollenhoven, R.
    Frostegard, J.
    LUPUS, 2016, 25 (14) : 1602 - 1609
  • [44] Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis?
    Zardi, Enrico M.
    Afeltra, Antonella
    AUTOIMMUNITY REVIEWS, 2010, 9 (10) : 684 - 686
  • [45] Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus
    Serikova, S. Yu.
    Kozlovskaya, N. L.
    Shilov, E. M.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (06) : 52 - 58
  • [46] Progression of carotid atherosclerosis in patients with systemic lupus erythematosus
    Rosa W. Telles
    Cristina C. D. Lanna
    Adriano J. Sousa
    Tulio P. Navarro
    Fabiana L. Souza
    Luciana A. Rodrigues
    Rodrigo C. P. Reis
    Antonio L. Ribeiro
    Clinical Rheumatology, 2013, 32 : 1293 - 1300
  • [47] Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
    Floris, Alberto
    Piga, Matteo
    Mangoni, Arduino Aleksander
    Bortoluzzi, Alessandra
    Erre, Gian Luca
    Cauli, Alberto
    MEDIATORS OF INFLAMMATION, 2018, 2018
  • [48] Metabolic syndrome in Argentinean patients with systemic lupus erythematosus
    Bellomio, V.
    Spindler, A.
    Lucero, E.
    Berman, A.
    Sueldo, R.
    Berman, H.
    Santana, M.
    Molina, M. J.
    Gongora, V.
    Cassano, G.
    Paira, S.
    Saurit, V.
    Retamozo, G.
    Alvarellos, A.
    Caerio, F.
    Alba, P.
    Gotero, M.
    Velozo, E. J.
    Ceballos, F.
    Soriano, E.
    Catoggio, L.
    Garcia, M. A.
    Eimon, A.
    Agueero, S.
    LUPUS, 2009, 18 (11) : 1019 - 1025
  • [49] An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus
    Parker, B.
    Ahmad, Y.
    Shelmerdine, J.
    Edlin, H.
    Yates, A. P.
    Teh, L-S
    Bruce, I. N.
    LUPUS, 2011, 20 (14) : 1459 - 1465
  • [50] Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus
    Jung, J-Y
    Koh, B-R
    Bae, C-B
    Kim, H-A
    Suh, C-H
    LUPUS, 2014, 23 (14) : 1517 - 1522